"Im Herzzentrum Göttingen arbeiten 14 Kliniken und Institute sowie die Geschäftseinheit Pflegedienst der Universitätsmedizin Göttingen auf dem Gebiet des Herz-Kreislauf-Systems und der Lunge eng zusammen. Die Kliniken und Institute sind zu einem interdisziplinären Zentrum zusammengeführt, um eine optimale und effiziente Krankenversorgung, Forschung und Lehre zu gewährleisten. Wesentliches Ziel des Herzzentrums ist es, eine qualitativ hochwertige Medizin patientenorientiert, aufgeschlossen und transparent zu praktizieren."

During the past decade, Herzzentrum Göttingen conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Herzzentrum Göttingen" #1 sponsor was "CVRx, Inc." with 3 trials, followed by "CytoSorbents, Inc" with 1 trials sponsored, "Edwards Lifesciences" with 1 trials sponsored, "LMU Klinikum" with 1 trials sponsored and "University Hospital Freiburg" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herzzentrum Göttingen" #1 collaborator was "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator, "Dr. Köhler Chemie (Alsbach-Hähnlein, Germany)" with 1 trials as a collaborator, "GEA (Frederiksberg, Denmark)" with 1 trials as a collaborator, "HP-Medica (Augsburg, Germany)" with 1 trials as a collaborator and "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Herzzentrum Göttingen" are "Heart Failure" (2 trials), "Acute Respiratory Distress Syndrome" (1 trials), "Cardiogenic Shock" (1 trials), "Corona Virus Infection" (1 trials) and "Critical Illness" (1 trials). Many other conditions were trialed in "Herzzentrum Göttingen" in a lesser frequency.

Most popular intervention types in "Herzzentrum Göttingen" are "Device" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "BAROSTIM NEO™ System" (2 trials), "Barostim Neo™ System" (1 trials), "CytoSorb" (1 trials), "Transcatheter Tricuspid Valve Repair" (1 trials) and "Transcatheter tricuspid valve treatment (TTVT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herzzentrum Göttingen" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Herzzentrum Göttingen". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Herzzentrum Göttingen, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Herzzentrum Göttingen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".